Suppr超能文献

肾脏疾病中β2-微球蛋白的肾脏处理:特别提及肝肾综合征

Renal handling of beta-2-microglobulin in renal disorders: with special reference to hepatorenal syndrome.

作者信息

Hall P W, Ricanati E S

出版信息

Nephron. 1981;27(2):62-6. doi: 10.1159/000182026.

Abstract

A study of serum beta 2-microglobulin and urinary beta 2-microglobulin in patients with liver and/or kidney disease was done to determine if such information is of diagnostic help. Serum concentrations and beta 2M/Cr clearance ratios are higher in patients with primary tubular disorders than in those with glomerular diseases, a finding unaltered by hepatic disease. These data suggest either an increased production or decreased tubular degradation of beta 2M, independent of the glomerular filtration rate (GFR), in primary tubular disorders. The marked increase in urinary beta 2-microglobulin that followed insertion of the peritoneal-jugular shunt is evidence that this procedure resulted in improvement of the GFR, in previously underperfused nephrons.

摘要

对患有肝脏和/或肾脏疾病的患者进行了血清β2-微球蛋白和尿β2-微球蛋白的研究,以确定此类信息是否具有诊断帮助。原发性肾小管疾病患者的血清浓度和β2M/Cr清除率高于肾小球疾病患者,这一发现不受肝脏疾病影响。这些数据表明,在原发性肾小管疾病中,β2M的产生增加或肾小管降解减少,与肾小球滤过率(GFR)无关。腹腔-颈静脉分流术后尿β2-微球蛋白显著增加,证明该手术改善了先前灌注不足的肾单位的GFR。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验